Structure

Physi-Chem Properties

Molecular Weight:  208.04
Volume:  195.172
LogP:  1.019
LogD:  0.215
LogS:  -1.918
# Rotatable Bonds:  0
TPSA:  90.9
# H-Bond Aceptor:  5
# H-Bond Donor:  3
# Rings:  2
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.566
Synthetic Accessibility Score:  2.656
Fsp3:  0.1
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.951
MDCK Permeability:  8.145625542965718e-06
Pgp-inhibitor:  0.001
Pgp-substrate:  0.623
Human Intestinal Absorption (HIA):  0.015
20% Bioavailability (F20%):  0.541
30% Bioavailability (F30%):  0.994

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.023
Plasma Protein Binding (PPB):  91.9661636352539%
Volume Distribution (VD):  0.481
Pgp-substrate:  11.318866729736328%

ADMET: Metabolism

CYP1A2-inhibitor:  0.745
CYP1A2-substrate:  0.781
CYP2C19-inhibitor:  0.043
CYP2C19-substrate:  0.06
CYP2C9-inhibitor:  0.389
CYP2C9-substrate:  0.667
CYP2D6-inhibitor:  0.13
CYP2D6-substrate:  0.252
CYP3A4-inhibitor:  0.043
CYP3A4-substrate:  0.091

ADMET: Excretion

Clearance (CL):  8.086
Half-life (T1/2):  0.89

ADMET: Toxicity

hERG Blockers:  0.035
Human Hepatotoxicity (H-HT):  0.087
Drug-inuced Liver Injury (DILI):  0.955
AMES Toxicity:  0.116
Rat Oral Acute Toxicity:  0.098
Maximum Recommended Daily Dose:  0.704
Skin Sensitization:  0.937
Carcinogencity:  0.062
Eye Corrosion:  0.239
Eye Irritation:  0.937
Respiratory Toxicity:  0.137

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC10093

Natural Product ID:  NPC10093
Common Name*:   FBJMEOFSLTXPKH-UHFFFAOYSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  FBJMEOFSLTXPKH-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C10H8O5/c1-4-2-5-3-6(11)8(12)9(13)7(5)10(14)15-4/h2-3,11-13H,1H3
SMILES:  Cc1cc2cc(c(c(c2c(=O)o1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   45093102
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0001890] Isocoumarins and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO28292 Streptomyces microflavus Species Streptomycetaceae Bacteria n.a. n.a. n.a. PMID[9918397]
NPO5951 Crotalaria ferruginea Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO839 Sorocea ilicifolia Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO5951 Crotalaria ferruginea Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO5951 Crotalaria ferruginea Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO5951 Crotalaria ferruginea Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28292 Streptomyces microflavus Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[UNPD]
NPO4791 Murrayella periclados Species Rhodomelaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO3095 Aster conspicuus Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO2935 Zanthoxylum parviflorum Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO25519 Kleinia tomentosa Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO17804 Melanocarpus albomyces Species Chaetomiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO839 Sorocea ilicifolia Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO17771 Senna didymobotrya Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO7740 Clitocybula oculus Species Tricholomataceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC10093 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC10093 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data